Shares of Rentokil Initial plc (NYSE:RTO – Get Free Report) have been assigned a consensus recommendation of “Hold” from the seven ratings firms that are covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $29.00.
Separately, Redburn Atlantic cut shares of Rentokil Initial from a “buy” rating to a “neutral” rating in a research report on Thursday, September 19th.
Get Our Latest Stock Report on RTO
Institutional Trading of Rentokil Initial
Rentokil Initial Trading Down 1.1 %
NYSE RTO opened at $25.71 on Friday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.96 and a current ratio of 1.04. Rentokil Initial has a one year low of $22.40 and a one year high of $34.07. The company’s 50 day moving average price is $25.09 and its 200 day moving average price is $27.89. The firm has a market capitalization of $12.98 billion, a price-to-earnings ratio of 18.11, a PEG ratio of 7.24 and a beta of 1.09.
Rentokil Initial Company Profile
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Read More
- Five stocks we like better than Rentokil Initial
- How to Invest in Biotech Stocks
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Consumer Staples Stocks, Explained
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.